Translating a screening questionnaire for spondyloarthritis in people with bowel disease
Checks French versions of two joint inflammation questionnaires for adults with bowel disease.
Key facts
- Who runs it
- University Hospital, Grenoble
- Where
- Grenoble, FranceSee the site
- Trial code
- Registry title
- Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
- Status
- Not yet recruiting
- People taking part
- 220 people, planned
- Started
- May 2025
- Planned end
- Jul 2026
- Type of study
- Observational
- Treatments tested
- Screening questionnaire
- Record updated
- 31 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with inflammatory bowel disease. They fill in two screening questionnaires for spondyloarthritis, once at a visit and again after 1 month.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Inflammatory bowel disease, as diagnosed by a gastroenterologist.
Main reasons for not taking part
- Difficulty understanding or reading French
- Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code
- No social security coverage
- Refusing to take part voluntarily
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patient with an inflammatory bowel disease according to gastroenterologist
Who cannot take part
- No exclusion criteria
- Difficulty for understanding or reading french
- Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code
- Patients with no social security coverage
- Patients refusing to participate voluntarily
Where in France
- university Hospital GrenobleGrenoble, FranceContact: XAVIER ROMAND, PHDNo longer taking part
About the trial
What the trial wants to find out
The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease.
Read full original descriptionShow less
DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease.
The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct.
Then, the main question is:
is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one.
Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.
The group in the trial
- People with inflammatory bowel disease
Patient followed in gastro-enterology for an inflammatory bowel disease. These represent every-patient in our study.
Treatment: Screening questionnaire
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Linguistical Validation of a Spondylo-arthritis Screening Tool for Patients Suffering From Inflammatory Bowel Disease
- Plain-language title
- Translating a screening questionnaire for spondyloarthritis in people with bowel diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 31 May 2025